Stay updated on ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.

Latest updates to the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an opportunity for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.5%
- Check39 days agoChange DetectedDifference0.6%
- Check46 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed clinical trial information and the addition of new collaborators, specifically the National Institutes of Health (NIH) and the National Cancer Institute (NCI).SummaryDifference31%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.5%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.7%
Stay in the know with updates to ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.